These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20966318)

  • 21. Pattern and chronological change of iodized oil retention in radiofrequency ablation-induced vascular injury area: differentiation from iodized oil retention in recurrent hepatocellular carcinoma on computed tomography.
    Lee JY; Kim YS; Rhim H; Lim HK; Choi D; Lee WJ
    J Comput Assist Tomogr; 2010; 34(3):354-61. PubMed ID: 20498535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver abscess after percutaneous radiofrequency ablation for hepatocellular carcinomas: frequency and risk factors.
    Choi D; Lim HK; Kim MJ; Kim SJ; Kim SH; Lee WJ; Lim JH; Paik SW; Yoo BC; Choi MS; Kim S
    AJR Am J Roentgenol; 2005 Jun; 184(6):1860-7. PubMed ID: 15908543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Laparoscopic and percutaneous ultrasound guided radiofrequency ablation for hepatocellular carcinoma: a preliminary study].
    Jung MK; Lee JH; Kim TS; Kim HS; Cho CM; Tak WY; Kweon YO; Kim SK; Choi YH; Chung JM
    Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):209-17. PubMed ID: 12499807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraductal chilled saline perfusion to prevent bile duct injury during percutaneous radiofrequency ablation for hepatocellular carcinoma.
    Ohnishi T; Yasuda I; Nishigaki Y; Hayashi H; Otsuji K; Mukai T; Enya M; Omar S; Soehendra N; Tomita E; Moriwaki H
    J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e410-5. PubMed ID: 17683503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of long-term effectiveness and complications of radiofrequency ablation with hepatectomy for small hepatocellular carcinoma.
    Fang Y; Chen W; Liang X; Li D; Lou H; Chen R; Wang K; Pan H
    J Gastroenterol Hepatol; 2014 Jan; 29(1):193-200. PubMed ID: 24224779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of therapeutic effects between radiofrequency ablation and percutaneous microwave coagulation therapy for small hepatocellular carcinomas.
    Ohmoto K; Yoshioka N; Tomiyama Y; Shibata N; Kawase T; Yoshida K; Kuboki M; Yamamoto S
    J Gastroenterol Hepatol; 2009 Feb; 24(2):223-7. PubMed ID: 18823439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study.
    Peng ZW; Lin XJ; Zhang YJ; Liang HH; Guo RP; Shi M; Chen MS
    Radiology; 2012 Mar; 262(3):1022-33. PubMed ID: 22357902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation.
    Hori T; Nagata K; Hasuike S; Onaga M; Motoda M; Moriuchi A; Iwakiri H; Uto H; Kato J; Ido A; Hayashi K; Tsubouchi H
    J Gastroenterol; 2003; 38(10):977-81. PubMed ID: 14614605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pain analysis in patients with hepatocellular carcinoma: irreversible electroporation versus radiofrequency ablation-initial observations.
    Narayanan G; Froud T; Lo K; Barbery KJ; Perez-Rojas E; Yrizarry J
    Cardiovasc Intervent Radiol; 2013 Feb; 36(1):176-82. PubMed ID: 22752100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intraoperative radiofrequency ablation (RFA) for irresectable liver malignancies.
    Tepel J; Hinz S; Klomp HJ; Kapischke M; Kremer B
    Eur J Surg Oncol; 2004 Jun; 30(5):551-5. PubMed ID: 15135485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Transarterial chemoembolization plus computed tomography-guided percutaneous radiofrequency ablation for small hepatocellular carcinoma in special locations].
    Guo YJ; Huang WS; Zhou B; Chen JW; Cai MY; Qian JS; Huang MS; Shan H; Zhu KS
    Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(33):2627-30. PubMed ID: 24360041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Experience of radiofrequency ablation therapy for hepatocellular carcinoma].
    Iwauchi T; Yamada N; Amano R; Ohira M; Nishino H; Hirakawa K
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1663-5. PubMed ID: 16315902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiofrequency ablation with hand-assisted laparoscopic surgery for the treatment of hepatocellular carcinoma in the caudate lobe.
    Ishiko T; Beppu T; Sugiyama S; Masuda T; Takahashi M; Komori H; Takamori H; Hirota M; Kanemitu K; Baba H
    Surg Laparosc Endosc Percutan Tech; 2008 Jun; 18(3):272-6. PubMed ID: 18574414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetics of indocyanine green removal from blood can be used to predict the size of the area removed by radiofrequency ablation of hepatic nodules.
    Sato S; Miyake T; Mishiro T; Furuta K; Azumi T; Oshima N; Takahashi Y; Rumi MA; Ishihara S; Adachi K; Amano Y; Kinoshita Y
    J Gastroenterol Hepatol; 2006 Nov; 21(11):1714-9. PubMed ID: 16984595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two cases of hepatocellular carcinoma located adjacent to the Glisson's capsule treated by laparoscopic radiofrequency ablation with intraductal chilled saline perfusion through an endoscopic nasobiliary drainage tube.
    Nakata Y; Haji S; Ishikawa H; Yasuda T; Nakai T; Takeyama Y; Shiozaki H
    Surg Laparosc Endosc Percutan Tech; 2010 Dec; 20(6):e189-92. PubMed ID: 21150399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
    Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tolerance of radiofrequency ablation by patients of hepatocellular carcinoma.
    Cheung TT; Ng KK; Poon RT; Fan ST
    J Hepatobiliary Pancreat Surg; 2009; 16(5):655-60. PubMed ID: 19370304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laparoscopic US-guided radiofrequency ablation of unresectable hepatocellular carcinoma in liver cirrhosis: feasibility and clinical outcome.
    Casaccia M; Andorno E; Nardi I; Troilo B; Barabino G; Santori G; Valente U
    J Laparoendosc Adv Surg Tech A; 2008 Dec; 18(6):797-801. PubMed ID: 18922065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors of intrahepatic biloma and secondary infection after thermal ablation for malignant hepatic tumors.
    Liu J; Wu Y; Xu E; Huang Q; Ye H; Tan L; Zheng R; Zeng Q; Li K
    Int J Hyperthermia; 2019; 36(1):980-985. PubMed ID: 31544547
    [No Abstract]   [Full Text] [Related]  

  • 40. Intraoperative and percutaneous radiofrequency thermal ablation in the treatment of hepatocellular carcinoma.
    Nicoli N; Casaril A; Marchiori L; Mangiante G; Marini G; Colombari R; Portuese A; Hasheminia AR
    Chir Ital; 2000; 52(1):29-40. PubMed ID: 10832524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.